LONDON BROKER RATINGS: Berenberg cuts Whitbread; Citi ups Severn Trent
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
| Price | 166.60p on 05-02-2026 at 19:20:08 |
|---|---|
| Change | 0.20p 0.12% |
| Buy | 166.60p |
| Sell | 166.40p |
| Last Trade: | Buy 896.00 at 166.60p |
| Day's Volume: | 2,601,250 |
| Last Close: | 166.60p |
| Open: | 165.40p |
| ISIN: | GB00B012BV22 |
| Day's Range | 162.20p - 167.00p |
| 52wk Range: | 155.00p - 295.00p |
| Market Capitalisation: | £421.25m |
| VWAP: | 165.18658p |
| Shares in Issue: | 252.85m |
Marshalls (MSLH) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 896 | 166.60p | Automatic Execution |
16:29:38 - 05-Feb-26 |
| Sell* | 4,680 | 166.40p | Automatic Execution |
16:29:28 - 05-Feb-26 |
| Sell* | 5,348 | 166.40p | Automatic Execution |
16:29:28 - 05-Feb-26 |
| Sell* | 6,013 | 166.30p | Ordinary |
16:29:27 - 05-Feb-26 |
| Sell* | 4,000 | 166.40p | Automatic Execution |
16:29:27 - 05-Feb-26 |
| Buy* | 94 | 166.40p | Automatic Execution |
16:29:27 - 05-Feb-26 |
| Buy* | 47 | 166.40p | Automatic Execution |
16:29:27 - 05-Feb-26 |
| Buy* | 782 | 166.40p | Automatic Execution |
16:29:15 - 05-Feb-26 |
| Sell* | 782 | 166.20p | Automatic Execution |
16:29:15 - 05-Feb-26 |
| Buy* | 718 | 166.40p | Automatic Execution |
16:29:15 - 05-Feb-26 |
Marshalls (MSLH) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 19th Jan 2026 7:01 am | RNS | Trading Statement |
| 19th Jan 2026 7:00 am | RNS | Directorate change |
| 9th Jan 2026 12:40 pm | RNS | Director/PDMR Shareholding |
| 9th Jan 2026 12:38 pm | RNS | Director/PDMR Shareholding |
| 6th Jan 2026 9:36 am | RNS | Notice of Trading Update |
| 9th Dec 2025 3:21 pm | RNS | Director/PDMR Shareholding |
| 27th Nov 2025 7:00 am | RNS | Board changes |
| 12th Nov 2025 7:00 am | RNS | Trading Update |
| 10th Nov 2025 10:30 am | RNS | Director/PDMR Shareholding |
| 10th Nov 2025 10:29 am | RNS | Director/PDMR Shareholding |